can semaglutide cause heart issues GLP-1 agonists like Ozempic may reduce cardiovascular events by 20% Research shows semaglutide — commonly

Provenzano, M

Concerns around misuse and market practices The commercialization of obesity drugs has also raised several concerns: Increasing availability without proper prescriptions Off-label use among individuals without clinical indications Marketing of these drugs as quick weight-loss solutions Entry of inadequately tested products positioned as supplements Such practices pose risks to patient safety and may undermine confidence in these therapies if adverse events increase

Avoiding these simple pitfalls is just as important as the refrigeration itself

In most cases, the companies offering the prescriptions and the pharmacies filling them are safe and legitimate